First Time Loading...

Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 20.08 USD 3.61% Market Closed
Updated: May 4, 2024

Kiniksa Pharmaceuticals Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kiniksa Pharmaceuticals Ltd
Operating Income Peer Comparison

Comparables:

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Operating Income
-$30.5m
CAGR 3-Years
44%
CAGR 5-Years
28%
CAGR 10-Years
N/A

See Also

What is Kiniksa Pharmaceuticals Ltd's Operating Income?
Operating Income
-30.5m USD

Based on the financial report for Mar 31, 2024, Kiniksa Pharmaceuticals Ltd's Operating Income amounts to -30.5m USD.

What is Kiniksa Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
28%

The average annual Operating Income growth rates for Kiniksa Pharmaceuticals Ltd have been 44% over the past three years , 28% over the past five years .